Peer-reviewedCC BYThe journal of pathology. Clinical research
PRAME predicting outcome in uveal melanoma
4 affiliations
- 1Dublin City University
- 2Research Foundation Royal Victoria Eye & Ear Hospital
- 3National Ophthalmic Pathology Laboratory, Department of Pathology
- 4Department of Medical Oncology, St. Vincent's University Hospital
Related
- BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression
- Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
- Diagnostic Utility of PRAME Immunohistochemistry for Distinguishing Acral Melanoma From Acral Melanocytic Nevi
- Uveal melanoma: In the era of new treatments
- 114 CXCL6 emerges as a novel marker of an immunosuppressive, angiogenic, and epithelial-mesenchymal transition (EMT)-enriched metastatic program in uveal melanoma (UM)
BibTeX
@article{owens2026prame,
title = {{PRAME predicting outcome in uveal melanoma}},
author = {Sally Owens and Naomi Walsh and Noel Horgan and Patrick Murtagh and Katie Hanratty and Grainne Finegan and Laura Ivers and John Crown and Susan Kennedy},
journal = {The journal of pathology. Clinical research},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13662831},
note = {CC BY},
}
RIS
TY - JOUR
TI - PRAME predicting outcome in uveal melanoma
AU - Sally Owens
AU - Naomi Walsh
AU - Noel Horgan
AU - Patrick Murtagh
AU - Katie Hanratty
AU - Grainne Finegan
AU - Laura Ivers
AU - John Crown
AU - Susan Kennedy
PY - 2026
DA - 2026/10/14
JO - The journal of pathology. Clinical research
UR - https://europepmc.org/article/PMC/PMC13662831
SN - 2056-4538
ER -